THE INVESTOR

메뉴열기

KOSDAQ trading suspended on bio shares surge

PUBLISHED : January 12, 2018 - 14:57

UPDATED : January 12, 2018 - 14:57

  • 본문폰트 작게
  • 본문폰트 크게
  • 페이스북
  • 트위터
  • sms


[THE INVESTOR] The Korea Exchange temporarily suspended trading of the KOSDAQ market on Jan. 12 afternoon as the secondary market jumped more than 3 percent on a bio stock rally.

KOSDAQ rose 3.69 percent to 883.98 points shortly before 2 p.m., leading to a five-minute sidecar, a restraining measure adopted in case of a sudden market fluctuation, the Seoul bourse operator said.

The order was issued for the first time since June 2016, when Britain voted to exit the European Union.

Sharp gains in leading bio shares drove up the overall market.

Celltrion, KOSDAQ’s No. 1 market cap, skyrocketed 19 percent, and its affiliate Celltrion Healthcare rose nearly 25 percent shortly after 2 p.m.

By Alex Lee and newswires (alexlee@heraldcorp.com)

  • 페이스북
  • 트위터
  • sms
최상단으로
Herald Corporation|CEO : Kwon Chung Won
JUVENILE PROTECTION MANAGER : Shin Chang Hoon
Company Registration No. 104-81-06004
Mail-Order Business Registration 2016 - Seoul Yongsan - 00590
Huam-ro 4-gil 10, Yongsan-gu, Seoul, Korea
T : +82-2-727-0615|Business info
COPYRIGHT HERALD CORPORATION. ALL RIGHTS RESERVED.